1. Home
  2. OBLG vs ENSC Comparison

OBLG vs ENSC Comparison

Compare OBLG & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBLG
  • ENSC
  • Stock Information
  • Founded
  • OBLG 2000
  • ENSC 2003
  • Country
  • OBLG United States
  • ENSC United States
  • Employees
  • OBLG N/A
  • ENSC N/A
  • Industry
  • OBLG Computer Software: Programming Data Processing
  • ENSC Biotechnology: Pharmaceutical Preparations
  • Sector
  • OBLG Technology
  • ENSC Health Care
  • Exchange
  • OBLG Nasdaq
  • ENSC Nasdaq
  • Market Cap
  • OBLG 4.5M
  • ENSC 4.9M
  • IPO Year
  • OBLG N/A
  • ENSC N/A
  • Fundamental
  • Price
  • OBLG $3.12
  • ENSC $2.22
  • Analyst Decision
  • OBLG
  • ENSC
  • Analyst Count
  • OBLG 0
  • ENSC 0
  • Target Price
  • OBLG N/A
  • ENSC N/A
  • AVG Volume (30 Days)
  • OBLG 207.1K
  • ENSC 230.3K
  • Earning Date
  • OBLG 08-06-2025
  • ENSC 08-13-2025
  • Dividend Yield
  • OBLG N/A
  • ENSC N/A
  • EPS Growth
  • OBLG N/A
  • ENSC N/A
  • EPS
  • OBLG N/A
  • ENSC N/A
  • Revenue
  • OBLG $2,374,000.00
  • ENSC $6,224,081.00
  • Revenue This Year
  • OBLG N/A
  • ENSC N/A
  • Revenue Next Year
  • OBLG N/A
  • ENSC $1,381.48
  • P/E Ratio
  • OBLG N/A
  • ENSC N/A
  • Revenue Growth
  • OBLG N/A
  • ENSC 256.35
  • 52 Week Low
  • OBLG $1.91
  • ENSC $1.62
  • 52 Week High
  • OBLG $8.40
  • ENSC $14.67
  • Technical
  • Relative Strength Index (RSI)
  • OBLG 44.15
  • ENSC 49.53
  • Support Level
  • OBLG $3.30
  • ENSC $2.02
  • Resistance Level
  • OBLG $4.13
  • ENSC $2.30
  • Average True Range (ATR)
  • OBLG 0.50
  • ENSC 0.14
  • MACD
  • OBLG -0.10
  • ENSC 0.02
  • Stochastic Oscillator
  • OBLG 18.23
  • ENSC 43.40

About OBLG Oblong Inc.

Oblong Inc is a provider of patented multi-stream collaboration products and managed services for network solutions and video collaboration. The company's flagship product Mezzanine is the technology platform that defines computing: simultaneous multi-user, multi-screen, multi-device, and multi-location for dynamic and immersive visual collaboration. Mezzanine transforms routine meetings and workflows into agile, engaging experiences by making data visible and accessible in a collaborative setting. The mezzanine enables multiple, concurrent pieces of content to be shared, manipulated, created, and captured across distance. It serves various industries including aerospace, consulting, executive search, broadcast media, technology, financial services, education, healthcare, and real estate.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: